Related Experiment Video
Updated: Mar 28, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
Published on: June 17, 2025
Update on ocular cicatricial pemphigoid and emerging treatments
Munther M Queisi1, Mike Zein1, Neerav Lamba1
1Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA; Ocular Immunology and Uveitis Foundation, Waltham, Massachusetts, USA.
Abstract:
Mucous membrane pemphigoid is a systemic disorder that primarily affects mucous membranes. When localized to the conjunctiva, it is known as ocular cicatricial pemphigoid, a potentially blinding disease. Ocular cicatricial pemphigoid is an indication for systemic immunosuppressive treatment to achieve adequate remission. Immunosuppressive agents are selected with a "stepladder" approach, commencing with medications having the fewest side effects. We provide an update of the literature on immunomodulatory agents since 2011 as additional treatment modalities have been explored in the last 4 years.

